switch from tirzepatide to retatrutide vs. Retatrutide: Key Differences Explained Retatrutide for weight loss: Study

Besides improving blood sugar control and promoting weight loss, these drugs may also reduce the risk of cardiovascular and kidney disease

This may limit the generalizability to younger populations, who have a lower baseline risk of AF/Aflutter and stroke [79, 80]

PMID: 27138887

One, patients may be new to GLP-1 medications and are slowly adjusting or they may be on too high of a dose too fast

Thus, it is feasible that even if there may be a tumor-promoting effect that the duration of drug exposure may not be sufficient to significantly increase the risk of tumorigenesis

Questa popolazione, notoriamente pi difficile da trattare con i farmaci per la perdita peso, ha mostrato risultati comunque significativi